Navigation Links
Takeda Initiates Phase 3 Clinical Trial Program in the United States, Latin America, and Europe for Investigational Type 2 Diabetes Therapy TAK-875
Date:10/17/2011

OSAKA, Japan, Oct. 18, 2011 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiaries, Takeda Global Research & Development Center, Inc. ("TGRD U.S."), and Takeda Global Research & Development Centre (Europe), Ltd. ("TGRD Europe"), announced today the initiation of the Company's Phase 3 clinical trial program for TAK-875, an investigational therapy for type 2 diabetes. The program will be conducted across the United States (U.S.), Latin America, and Europe. TAK-875 is the first GPR40 agonist to reach late stage (Phase 3) clinical development.

Completed studies of TAK-875, discovered by Takeda, have suggested glucose-lowering effects in patients with type 2 diabetes by enhancing glucose-dependent insulin secretion.

"Takeda is committed to enhancing the clinical investigation of TAK-875 in order to accelerate the development of a potential new type 2 diabetes treatment option for patients and healthcare professionals," said Thomas Strack, M.D., vice president, clinical science, Takeda Global Research & Development Center, Inc., U.S. "An outcome of our robust focus on diabetes over many years, TAK-875 was discovered by Takeda based on our GPCR research and is the first GPR40 agonist to reach late stage (Phase 3) clinical development. TAK-875 is being developed globally, with Phase 3 trials already underway in Japan."

The first Phase 3 trial in the U.S./Europe program, a double-blind, randomized, 24-week safety and efficacy study, will enroll approximately 450 patients with type 2 diabetes who are not adequately controlled on diet and exercise, at approximately 140 sites in the U.S., Latin America, and Europe. The study's primary endpoint will be the change in HbA1c at week 24 while other endpoints will include the assessment of a clinically meaningful response based on reaching HbA1c targets, changes in fasting plasma glucose (FPG) and two-hour postprandial plasma glucose (PPG). Results are ex
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Takeda Completes Acquisition and Names New CEO of Nycomed
2. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
3. Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
4. Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
5. Takeda to Acquire Nycomed
6. Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
7. Intra-Cellular Therapies and Takeda Enter into Worldwide Collaboration to Develop and Commercialize Compounds for Schizophrenia
8. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
9. Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension
10. Takeda Enters Into Global Strategic Partnerships With Covance and Quintiles
11. Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOS® (pioglitazone HCI), ACTOplus met® (pioglitazone HCl and metformin HCl) and duetact® (pioglitazone HCl and glimepiride)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... NEW YORK , Aug. 20, 2014 /PRNewswire/ ... report is available in its catalogue: ... U.S. IVD Industry http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html ... Care Act" (H.R. 3590) is complex legislation that ... many of its provisions are beginning to take ...
(Date:8/20/2014)... 2014 Research and Markets ... Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) ... to their offering. A new ... geography) - Size, Share, Global Trends, Company Profiles, ... Forecast, 2013 - 2020", suggests that the global ...
(Date:8/20/2014)... NEW YORK , Aug. 20, 2014 ... market research report is available in its ... (The Market for Bluetooth, RFID, Zigbee, UWB ... http://www.reportlinker.com/p0652514/Wireless-Opportunities-in-Healthcare-The-Market-for-Bluetooth-RFID-Zigbee-UWB-WWAN-WMAN-WLAN-and-other-technologies.html ... Market for Bluetooth, RFID, Zigbee, UWB WWAN, ...
Breaking Medicine Technology:The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 2Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 2Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 3Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 4Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 5Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 6Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 7Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 8Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 9Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 10Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 11Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 12Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 13Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 14Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 15Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 16
... 2010 The American Lung Association released its ... Opportunities: Influenza and Pneumonia Vaccination in Older Adults," ... influenza and pneumonia vaccination rates among older Americans. ... because despite the ready availability of safe and ...
... Richard Merkin, President and CEO, Heritage Provider Network was featured ... and David Asman revealing HPN,s new challenging $3 million Health ... "We want in on that," Clayman told her ... The HPN Health Prize is designed to foster ...
Cached Medicine Technology:American Lung Association Recognizes Older Adults Vaccination Day with Release of New Report Examining Disparities in Influenza and Pneumonia Vaccination Rates Among Older Americans 2American Lung Association Recognizes Older Adults Vaccination Day with Release of New Report Examining Disparities in Influenza and Pneumonia Vaccination Rates Among Older Americans 3American Lung Association Recognizes Older Adults Vaccination Day with Release of New Report Examining Disparities in Influenza and Pneumonia Vaccination Rates Among Older Americans 4Dr. Richard Merkin, President and CEO, Heritage Provider Network, Featured on Fox Business News, Bulls and Bears with Liz Clayman and David Asman, Revealing Challenge of $3 Million HPN Health Prize, Saving $30 Billion in Health Care Costs 2Dr. Richard Merkin, President and CEO, Heritage Provider Network, Featured on Fox Business News, Bulls and Bears with Liz Clayman and David Asman, Revealing Challenge of $3 Million HPN Health Prize, Saving $30 Billion in Health Care Costs 3
(Date:8/21/2014)... Beverly Hills Medical Center of Kuwait is ... patients TearLab, a new diagnostic option for measuring tear production ... , “ TearLab is a revolutionary new testing method ... measure the amount of tears a patient produces and take ... Zein, Medical Director at the Kuwait medical center. “The test ...
(Date:8/21/2014)... CA (PRWEB) August 21, 2014 Prosthodontists Dr. ... to India next month to provide workshops on full mouth ... southern India city of Bangalore in late September. , “Full ... “Full mouth rehabilitation means making sure all of the elements ... bones – all work together.” , Dr. Jivraj, who has ...
(Date:8/21/2014)... 2014 Atlantic Information Services, Inc. (AIS) ... News and The AIS Report on Blue Cross & ... Blue Shield Association or its member companies) — is ... in AIS’s Management Insight Series. Bundled Payment Models: ... two insurers — Horizon Healthcare Services, Inc. and Arkansas ...
(Date:8/21/2014)... If chocolate is good for the brain ... very happy and healthy. Tracie is the latest winner of ... She and three of her coworkers will be enjoying an ... world-famous Chocolate Spa® at The Hotel Hershey® in Hershey, Pennsylvania. ... in the ambulatory surgery center at Connecticut Children’s Medical Center ...
(Date:8/21/2014)... Inc. magazine ranked Centurion Service Group No. 3745 ... of the nation's fastest-growing private companies. The list represents ... of the economy—America’s independent entrepreneurs. Companies such as Yelp, ... other well-known names gained early exposure as members of ... been named to the Inc. 5000 list. We have ...
Breaking Medicine News(10 mins):Health News:Beverly Hills Kuwait is the First Medical Center in Kuwait with Access to TearLab 2Health News:Oxnard Cosmetic Dentist Earns Invitation to Speak in India 2Health News:Oxnard Cosmetic Dentist Earns Invitation to Speak in India 3Health News:Oxnard Cosmetic Dentist Earns Invitation to Speak in India 4Health News:New AIS Report Highlights Two Case Studies of Bundled Payment Models 2Health News:Connecticut Nurse Wins a Sweet Prize from California Casualty 2Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 2Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 3Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 4
... Louisiana Tumor Registry (LTR) at the LSU Health Sciences ... awarded a $12 million contract over seven years by ... a SEER (Surveillance, Epidemiology and End Results) Program-designated cancer ... in the United States., "The SEER Program is the ...
... An experimental vaccine based on a virus that causes ... in some cases of advanced cancer, according to researchers ... is able to stimulate an immune response, even in ... most patients with advanced cancer experience. Scientists ...
... refuse or request the withdrawal of any unwanted treatment. In ... Clinic Proceedings , investigators explore the legal and ethical permissibility ... assist device (VAD). The left-VAD (LVAD) is a ... heart failure who are awaiting a heart transplant. This technology ...
... controversial hypothesis that venous congestionchronic cerebrospinal venous insufficiency ... This theory has resulted in many MS patients ... unproven by clinical trials. The studies refuting the ... on the subject, are available today in ...
... of healing according to the way they cope and their ... health psychologist at The University of Nottingham. The large ... has shown that the way patients cope with the condition ... or worsens. The work by Professor Kavita Vedhara from ...
... able to significantly reduce the radiation dose associated with ... one day dose optimization workshop provided by the Royal ... supported by the local state health department, according to ... Journal of the American College of Radiology (www.jacr.org). ...
Cached Medicine News:Health News:LA Tumor Registry at LSUHSC awarded $12 million SEER contract by NCI 2Health News:LA Tumor Registry at LSUHSC awarded $12 million SEER contract by NCI 3Health News:Alphavirus-based vaccine may slow some cancers 2Health News:Mayo Clinic finds withdrawing ventricular assist device support ethical 2Health News:New studies question vascular multiple sclerosis hypothesis and treatment 2Health News:New studies question vascular multiple sclerosis hypothesis and treatment 3Health News:Mind over matter? The psychology of healing 2
Needle tip electrode, davol advantage electrosurgical attachments, 33cm (with extendible outer sheath), non-sterile. These products are supplied non-sterile and must be sterilized before use. Reusabl...
The Accuref 8001 allows you to measure much smaller pupils than conventional units and 3 step Target light adjuster ensures accurate results....
The amazingly compact refractor VISUTRON 900+ follows a simple principle: one knob is enough. It offers the user maximal ease, speed, and economics. The quick and silent change of glasses helps the ...
Sterile free isotonic balanced salt solution...
Medicine Products: